Direct evidence for rejection of tumour allografts in Str. pyogenes toxins-treated mice correlated with antistreptolysine O level in serum.
D000818:Animals; D000989:Antistreptolysin / Q000097:blood*; D002924:Ciliary Body; D003536:Cystadenocarcinoma / Q000276:immunology*; D004731:Endotoxins / Q000494:pharmacology*; D004847:Epithelial Cells; D005260:Female; D006087:Graft vs Host Reaction; D006821:Hyaluronoglucosaminidase / Q000008:administration & dosage; D007114:Immunization; D008297:Male; D008325:Mammary Neoplasms, Experimental; D051379:Mice; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000276:immunology; D013194:Staining and Labeling; D013297:Streptococcus pyogenes / Q000276:immunology*; D013299:Streptodornase and Streptokinase / Q000008:administration & dosage; D013301:Streptolysins / Q000008:administration & dosage; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D004731:Endotoxins; D013301:Streptolysins; D000989:Antistreptolysin; D013299:Streptodornase and Streptokinase; D006821:Hyaluronoglucosaminidase